P9WJF1 (DPRE1_MYCTU) Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)

Decaprenylphosphoryl-beta-D-ribose oxidase UniProtKBInterProSTRINGInteractive Modelling

461 aa; Sequence (Fasta) Identical sequences: Mycobacterium tuberculosis: P9WJF0; A5U9B9; Mycobacterium bovis: A0A0H3MC09; Mycobacterium tuberculosis variant africanum: U5JD70; Mycobacterium bovis: A0A1R3Y598; Mycobacterium tuberculosis variant pinnipedii: A0A328G3V0; Mycobacterium tuberculosis: A0A045J9I4

Sequence Features

Add
 17G -> C (in strain: TRC11; Ty38c-resistant mutant strain lacking Rv3406, but sensitive to moxifloxacin)
 314Y -> C (in a spontaneous TCA1-resistant mutant strain, but sensitive to BTZ)
 368L -> P (in strain: TRC12; Ty38c-resistant mutant strain lacking Rv3406, but sensitive to moxifloxacin)
 387C -> G (in strain: NTB9; BTZ043-resistant)
 387C -> S (in strain: NTB1; BTZ043-resistant)
 53-63FAD
 122-125FAD
 129-132FAD
 30-161FAD linked oxidase, N-terminal
IPR006094PF01565
 398-457D-arabinono-1,4-lactone oxidase
IPR007173PF04030

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRange
Crystal structure of M. tuberculosis DprE1 in complex with the non-covalent inhibitor QN118monomer FAD;R57;4p8n4-461
Assess
Crystal structure of M. tuberculosis DprE1 in complex with the non-covalent inhibitor Ty21cmonomer FAD;38C;IMD;4p8y4-461
Assess
Crystal structure of M. tuberculosis DprE1 in complex with the non-covalent inhibitor Ty36cmonomer FAD;36C;IMD;4p8l5-461
Assess
Crystal structure of M. tuberculosis DprE1 in complex with the non-covalent inhibitor Ty38cmonomer FAD;38C;4p8k5-461
Assess
Crystal structure of M. tuberculosis DprE1 in complex with PBTZ169monomer 26J;FAD;GOL;4ncr6-461
Assess
Mycobacterium tuberculosis DprE1 mutant Y314C in complex with TCA1monomer FAD;1W6;5oel6-461
Assess
Crystal structure of M. tuberculosis DprE1 in complex with the non-covalent inhibitor QN127monomer FAD;RG2;2J3;IMD;4p8p6-461
Assess
Crystal structure of M. tuberculosis DprE1 in complex with the non-covalent inhibitor QN129monomer FAD;R26;IMD;2J3;4p8t6-461
Assess
Crystal structure of M. tuberculosis DprE1 in complex with the non-covalent inhibitor QN127monomer FAD;Y22;IMD;2J3;4p8c7-461
Assess
Mycobacterium tuberculosis DprE1 - hexagonal crystal formmonomer FAD;4feh7-461
Assess
Mycobacterium tuberculosis DprE1 in complex with CMP2monomer FAD;IMD;G1T;6hfv7-461
Assess
M tuberculosis DprE1 in complex with a covalently bound nitrobenzothiazinonemonomer 26J;FAD;6hf37-461
Assess
Mycobacterium tuberculosis DprE1 - monoclinic crystal formmonomer FAD;IMD;4fdp7-461
Assess
Mycobacterium tuberculosis DprE1 in complex with inhibitor TCA020monomer FAD;P95;IMD;5oeq7-461
Assess
M tuberculosis DprE1 in complex with BTZ043monomer 0SK;FAD;IMD;6hez7-461
Assess
Crystal structure of M. tuberculosis in complex with a cBT - non-covalent adductmonomer FAD;IMD;2R2;4pfd7-461
Assess
Mycobacterium tuberculosis DprE1 in complex with inhibitor TCA481monomer FAD;9T2;IMD;5oep7-461
Assess
M. tuberculosis DprE1 covalently bound to a nitrobenzoxacinone.monomer FAD;G1H;6hf07-461
Assess
Mycobacterium tuberculosis DprE1 in complex with CT325 - hexagonal crystal formmonomer FAD;0T4;4fdn7-461
Assess
Mycobacterium tuberculosis DprE1 in complex with CT319monomer FAD;0T5;4fdo7-461
Assess
Mycobacterium tuberculosis DprE1 in complex with CMP1monomer FAD;IMD;G1T;6hfw7-461
Assess
Mycobacterium tuberculosis DprE1 in complex with CT325 - monoclinic crystal formmonomer FAD;0T4;IMD;4ff67-461
Assess
Crystal structure of M. tuberculosis DprE1 in complex with the non-covalent inhibitor QN114monomer FAD;R58;2J3;IMD;4p8m8-461
Assess
Crystal structure of M. tuberculosis DprE1 in complex with sPBTZ169 (sulfonylPBTZ)monomer FAD;EQ8;6g838-461
Assess
Crystal structure of M. tuberculosis in complex with BTO - covalent adductmonomer FAD;N77;4pfa8-461
Assess
Crystal structure of M. tuberculosis DprE1 in complex with the nitro-benzothiazole 6amonomer FAD;O95;4p8h8-461
Assess